Get In Touch
Have any questions or comments about the content you see on this page?
John Maraganore
October 28, 2021
Alnylam Names Dr. Yvonne Greenstreet New CEO
Dr. Yvonne Greenstreet, currently Alnylam's President and COO, has been named Alnylam's new CEO effective year-end 2021, taking over from Dr. John Maraganore.
Read More ›
June 9, 2020
John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ...
In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point...
Read More ›
May 1, 2020
John Maraganore on the "I Am BIO" Podcast: Destroying COVID's Genome
Our CEO John Maraganore recently spoke with Biotechnology Innovation Organization (BIO) CEO and Chairman Jim Greenwood on the "I Am BIO" podcast.
Read More ›
April 11, 2019
Letter to the Editor: Federal Research is Important, but Companies Turn it Into Actual Tre ...
John Maraganore wrote a Letter to the Editor in The Washington Post about the importance of federal research...
Read More ›
January 3, 2019
John Maraganore Talks RNAi on Chemical & Engineering News Podcast
John Maraganore talks with Chemical & Engineering News' Lisa Jarvis and Ryan Cross on this episode of C&EN's Stereo Chemistry podcast.
Read More ›
December 11, 2018
John Maraganore Named to Bloomberg 50 List for 2018
Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018.
Read More ›
May 9, 2018
First Rounders: John Maraganore
Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech.
Read More ›